Acquiring Company
SpyGlassPharma
Acquired Company
Santen Holdings US
Aliso ViejoCaliforniaBiotechnologyHealthcareHealth CareManufacturingBiotechnologyHealth CareTherapeuticsDescription
On October 1, 2026, SpyGlass Pharma, Inc. announced the acquisition of Santen Holdings US, Inc. through a Stock Purchase Agreement. This strategic acquisition aims to enhance SpyGlass's portfolio in the ophthalmic sector. The transaction reflects SpyGlass's commitment to expanding its reach and capabilities.
Fundz sees it the moment SpyGlassPharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Santen Holdings US?
Santen Holdings US was acquired by SpyGlassPharma, based in Aliso Viejo. The deal was reported on October 1, 2026. SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. SpyGlassPharma is publicly traded (SGP) and operates in Biotechnology.
When did SpyGlassPharma acquire Santen Holdings US?
SpyGlassPharma's acquisition of Santen Holdings US was reported on October 1, 2026. On October 1, 2026, SpyGlass Pharma, Inc. announced the acquisition of Santen Holdings US, Inc. through a Stock Purchase Agreement. This strategic acquisition aims to enhance SpyGlass's portfolio in the ophthalmic sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Santen Holdings US do?
Santen Holdings US, Inc. is a subsidiary of Santen Pharmaceutical Co., Ltd, a global company specializing in developing therapeutic and surgical solutions for eye diseases. It is privately held, operating in Manufacturing, and is based in California.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.